Ana Marcu

7PUBLICATIONS
77CO-AUTHORS
Molecular targetsTumour immunologyInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 19, 2023
Systematic discovery of neoepitope-HLA pairs for neoantigens shared among patients and tumor types.

Hem R Gurung, Amy J Heidersbach, Martine Darwish

|Sep 02, 2022
Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade.

Fiamma Berner, David Bomze, Christa Lichtensteiger

|Sep 23, 2021
BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity.

Zsófia Agnes Bittner, Xiao Liu, Maria Mateo Tortola

|Apr 16, 2021
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy.

Ana Marcu, Leon Bichmann, Leon Kuchenbecker

|Dec 12, 2018
The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy.

Tatjana Bilich, Annika Nelde, Leon Bichmann

|Nov 29, 2018
TAPBPR mediates peptide dissociation from MHC class I using a leucine lever.

F Tudor Ilca, Andreas Neerincx, Clemens Hermann

Pageof 2

Frequent Collaborators

3 joint publications

Stefan Stevanović

2 joint publications

Lena Katharina Freudenmann

2 joint publications

Markus W Löffler

2 joint publications

Juliane Walz